SEARCH

SEARCH BY CITATION

References

  • 1
    Kurman RJ,Toki T,Schiffman MH. Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am J Surg Pathol 1993; 17: 13345.
  • 2
    Preti M,van Seters M,Sideri M,van Beurden M. Squamous vulvar intraepithelial neoplasia. Clin Obstet Gynecol 2005; 48: 84561.
  • 3
    Sideri M,Jones RW,Wilkinson EJ,Preti M,Heller DS,Scurry J,Haefner H,Neill S. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology. ISSVD Vulvar Oncology Subcommittee. J Reprod Med 2005; 50: 80710.
  • 4
    Regauer S,Liegl B,Reich O. Early vulvar lichen sclerosus: a histopathological challenge. Histopathology 2005; 47: 3407.
  • 5
    Yang B,Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol 2000; 24: 42941.
  • 6
    Fox H,Wells M. Recent advances in the pathology of the vulva. Histopathology 2003; 42: 20916.
  • 7
    van Beurden M,van der Vange N,Ten Kate FJ,de Craen AJ,Schilthuis MS,Lammes FB. Restricted surgical management of vulvar intraepithelial neoplasia 3: focus on exclusion of invasion and on relief of symptoms. Int J Gynecol Cancer 1998; 8: 737.
  • 8
    Hording U,Daugaard S,Junge J,Lundvall F. Human papillomaviruses and multifocal genital neoplasia. Int J Gynecol Pathol 1996; 15: 2304.
  • 9
    van der Avoort IAM,Shirango H,Hoevenaars BM,Grefte JM,de Hullu JA,de Wilde PC,Bulten J,Melchers WJ,Massuger LFAG. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol 2006; 25: 229.
  • 10
    van Seters M,van Beurden M,de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 2005; 97: 64551.
  • 11
    Sharpless NE,DePinho RA. The INK4A/ARF locus and its two gene products. Curr Opin Genet Dev 1999; 9: 2230.
  • 12
    zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 34250.
  • 13
    Cattoretti G,Becker MH,Key G,Duchrow M,Schluter C,Galle J,Gerdes J. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 35763.
  • 14
    Bulten J,van der Laak JA,Gemmink JH,Pahlplatz MM,de Wilde PC,Hanselaar AG. MIB1, a promising marker for the classification of cervical intraepithelial neoplasia. J Pathol 1996; 178: 26873.
  • 15
    Kruse AJ,Baak JP,de Bruin PC,Jiwa M,Snijders WP,Boodt PJ,Fons G,Houben PW. The HS Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading. J Pathol 2001; 193: 4854.
  • 16
    Modesitt SC,Groben PA,Walton LA,Fowler WCJr,Van Le L. Expression of Ki-67 in vulvar carcinoma and vulvar intraepithelial neoplasia III: correlation with clinical prognostic factors. Gynecol Oncol 2000; 76: 515.
  • 17
    Salvesen HB,Iversen OE,Akslen LA. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas. Clin Cancer Res 1998; 4: 277985.
  • 18
    van Hamont D,Bulten J,Shirango H,Melchers WJ,Massuger LF,de Wilde PC. Biological behavior of CIN lesions is predictable by multiple parameter logistic regression models. Carcinogenesis 2008; 29: 8405.
  • 19
    Lee YY,Wilczynski SP,Chumakov A,Chih D,Koeffler HP. Carcinoma of the vulva: HPV and p53 mutations. Oncogene 1994; 9: 16559.
  • 20
    Kurman RJ,Norris HJ,Wilkinson EJ. Tumors of the cervix, vagina, and vulva. Atlas of tumor pathology. 3rd series edn. Fascicle 4. Washington: Armed Forces Institute of Pathology (AFIP), 1992.
  • 21
    Wilkinson EJ. Premalignant and malignant tumors of the vulva. In: KurmanRJ, ed. Blaustein's pathology of the female genital tract,2nd edn. New York: Springer-Verlag, 2002. 99149.
  • 22
    van der Avoort IAM,van der Laak JA,Paffen A,Grefte JMM,Massuger LFAG,de Wilde PCM,de Hullu JA,Bulten J. MIB1 expression in basal cell layer: a diagnostic tool to identify premalignancies of the vulva. Mod Pathol 2007; 20: 7708.
  • 23
    Kleter B,van Doorn LJ,ter Schegget J,Schrauwen L,van Krimpen K,Burger M,ter Harmsel B,Quint W. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998; 153: 17319.
  • 24
    Melchers WJ,Bakkers JM,Wang J,de Wilde PC,Boonstra H,Quint WG,Hanselaar AG. Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol 1999; 155: 14738.
  • 25
    Munoz N,Bosch FX,de Sanjose S,Herrero R,Castellsague X,Shah KV,Snijders PJ,Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 51827.
  • 26
    Keating JT,Cviko A,Riethdorf S,Riethdorf L,Quade BJ,Sun D,Duensing S,Sheets EE,Munger K,Crum CP. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001; 25: 88491.
  • 27
    O'Neill CJ,McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006; 13: 815.
  • 28
    Samama B,Lipsker D,Boehm N. p16 expression in relation to human papillomavirus in anogenital lesions. Hum Pathol 2006; 37: 51319.
  • 29
    Riethdorf S,Neffen EF,Cviko A,Loning T,Crum CP,Riethdorf L. p16 expression as biomarker for HPV 16-related vulvar neoplasias. Hum Pathol 2004; 35: 147783.
  • 30
    Santos M,Landolfi S,Olivella A,Lloveras B,Klaustermeier J,Suarez H,Alos L,Puig-Tintore LM,Campo E,Ordi J. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol 2006; 30: 134756.
  • 31
    Bulten J,van der Avoort IAM,Melchers WJ,Massuger LF,Grefte JM,Hanselaar AG,de Wilde PC. p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia. Gynecol Oncol 2006; 101: 48794.
  • 32
    El-Mofty SK,Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 2003; 27: 146370.
  • 33
    Smeets SJ,Hesselink AT,Speel EJ,Haesevoets A,Snijders PJ,Pawlita M,Meijer CJ,Braakhuis BJ,Leemans CR,Brakenhoff RH. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 246572.
  • 34
    Blokx WA,de Jong EM,de Wilde PC,Bulten J,Link MM,Ruiter DJ,van de Kerkhof PC. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals. Mod Pathol 2003; 16: 86978.
  • 35
    Lu DW,El-Mofty SK,Wang HL. Expression of p16. Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus. DNA Mod Pathol 2003; 16: 6929.
  • 36
    Klussmann JP,Gultekin E,Weissenborn SJ,Wieland U,Dries V,Dienes HP,Eckel HE,Pfister HJ,Fuchs PG. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003; 162: 74753.
  • 37
    Bosch FX,Manos MM,Munoz N,Sherman M,Jansen AM,Peto J,Schiffman MH,Moreno V,Kurman R,Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796802.
  • 38
    Brandenberger AW,Rudlinger R,Hanggi W,Bersinger NA,Dreher E. Detection of human papillomavirus in vulvar carcinoma. A study by in situ hybridisation. Arch Gynecol Obstet 1992; 252: 315.
  • 39
    Iwasawa A,Nieminen P,Lehtinen M,Paavonen J. Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction. Obstet Gynecol 1997; 89: 814.
  • 40
    Pinto AP,Schlecht NF,Pintos J,Kaiano J,Franco EL,Crum CP,Villa LL. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Gynecol Oncol 2004; 92: 85665.
  • 41
    Brustmann H,Naude S. Expression of topoisomerase IIα. Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. Gynecol Oncol 2002; 86: 1929.
  • 42
    Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol 2001; 20: 1630.
  • 43
    Lerma E,Esteller M,Herman JG,Prat J. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus. Hum Pathol 2002; 33: 11205.
  • 44
    Nogueira MC,Guedes Neto EP,Rosa MW,Zettler E,Zettler CG. Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva. Pathol Oncol Res 2006; 12: 1537.
  • 45
    Mulvany NJ,Allen DG. Differentiated intraepithelial neoplasia of the vulva. Int J Gynecol Pathol 2008; 27: 12535.
  • 46
    Stoler MH,Mills SE,Frierson HF. The vulva and vagina. In: MillsSE, ed. Sternberg's diagnostic surgical pathology 2004. Philadelphia: Lippincott Wiliams & Wilkins, 2004. 233376.
  • 47
    Liegl B,Regauer S. p53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia (d-VIN). Histopathology 2006; 48: 26874.
  • 48
    Medeiros F,Nascimento AF,Crum CP. Early vulvar squamous neoplasia: advances in classification, diagnosis, and differential diagnosis. Adv Anat Pathol 2005; 12: 206.